Prostaglandin 15d-PGJ2 Inhibits Androgen Receptor Signaling in Prostate Cancer Cells
نویسندگان
چکیده
منابع مشابه
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling
Castration resistance is a major obstacle to hormonal therapy for prostate cancer patients. Although androgen independence of prostate cancer growth is a known contributing factor to endocrine resistance, the mechanism of androgen receptor deregulation in endocrine resistance is still poorly understood. Herein, the CAMK2N1 was shown to contribute to the human prostate cancer cell growth and sur...
متن کاملBerberine Suppresses Androgen Receptor Signaling in Prostate Cancer Cells
The androgen signaling axis, activated by binding of androgens to the androgen receptor (AR), plays a critical role in all stages of prostate cancer. Androgen deprivation therapy (ADT) is a major component of the treatment regimen for advanced prostate cancer. However, after a moderate and short-term response, the disease eventually progresses to castration-resistant prostate cancer (CRPC), whi...
متن کاملSelenomethionine, Inhibits Androgen Receptor and Akt Signaling in Human Prostate Cancer Cells
Authors' A Biology, Pe Hershey C Biochemis Valhalla, Ne Correspon Molecular B Drive, Hers E-mail: rus
متن کاملAndrogen receptor signaling in androgen-refractory prostate cancer.
Prostate cancer is the second most prevalent cancer in males in the United States. Standard therapy relies on removing, or blocking the actions of, androgens. In most cases, this therapy results in a regression of the cancer because the prostate and most primary prostate tumors depend on androgens for growth and the avoidance of apoptosis. However, a portion of the cancers eventually relapse, a...
متن کاملHOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
HOX (homeobox) genes encode homeodomain-containing transcription factors critical to development, differentiation, and homeostasis. Their dysregulation has been implicated in a variety of cancers. Previously, we showed that a subset of genes of the HOXC cluster is upregulated in primary prostate tumors, lymph node metastases, and malignant prostate cell lines. In the present study, we show that...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Endocrinology
سال: 2013
ISSN: 0888-8809,1944-9917
DOI: 10.1210/me.2012-1313